BACKGROUND: Hyperglycemia on admission in patients with acute coronary syndromes is common, and it is a powerful predicator of increased risk of in hospital complications in patients with and without diabetes mellitus, high sensitivity creactive protein (hs-CRP) is a cardiovascular risk marker in patients with acute coronary syndrome.
INTRODUCTION
Over the last decades, evidence has accumulated that systemic inflammatory activity plays a key pathogenic role in atherosclerosis and cardiovascular disease (CVD) (1). This rationale has led to a search for clinically useful inflammatory biomarkers to improve CVD risk prediction . Prominent among possible candidates is C-reactive protein (CRP) as measured by a highly sensitive assay (2). C-reactive protein represents the classical acute-phase protein produced in the liver in response to inflammatory stimuli , and plasma levels of high-sensitive C reactive protein (hs-CRP)provide a sensitive marker of increased inflammatory activity in the arterial wall (3). Insulin resistance correlates closely with the risk of CVD , explaining some of the excess mortality in type 2 diabetes patients .There appears to be more-or-less linear relationship of cardiovascular risk to insulin resistence across the spectrum of normoglycemic patients with insulin resistence up to presenting with overt type 2 diabetes (4). Different studies revealed that hyperglycemia on admission in patients with acute coronary syndromes is common, and it is a powerful predicator of survival and increased risk of in-hospital complications in patients with and without diabetes mellitus (5 
RESULTS
Patients included in the study have a mean age of 61.07 ± 7.36 years. All patients were diabetics with admission glucose ranged from( 103 -430) a mean 239.08± 85.82 mg/dl. Admission glucose was categorized as (< 200 mg/dl and ≥200 mg/dl ). HbAIC level was also included as a continuous and categorized (≤6.5% and ≥6.5%). Hs C-reactive protein levels were measured in all patients including STEMI & NSTEMI.
In the studied patient with acute coronary syndromes the incidence of left ventricular failure increased incrementally with the levels of admission hyperglycemia either clinically as assessed by killip classification or by echocardiographic ejection fraction (EF%) which is statistically significant. Also there is a significant relation between increased level of hs-CRP with STEMI versus NSTEMI (P<0.0001). There is no significant relationship between level of glycosylated haemoglobin level and left ventricular function at admission or short term complications.
STATISTCS
Relation between hyperglycemia and characteristics of studied population: Comparison between patients with and without hyperglycemia as regard Inhospital complications:
DISCUSSION
The patient enrolled in this study allowed us to explore the relation between admission hyperglycemia and outcomes across a broad range of glucose concentration in patients presented by acute coronary syndromes. We found evidence a linear trend between admission glycemia and complications, particularly left ventricular failure. This result is similar with a large study's findings.(6 -8) Also elevated admission glucose is an important and significant predictor of in hospital outcome after STEMI and this is similar with the result of study by Rasoul et al. (9) But the prior long term glucose dysregulation detected by HbAIC is a covariate of other high risk clinical characteristics of interest and significant observation in our study.(10-11) The synergistic relationship between glucose level, c-reactive protein (hs-CRP) and risk of clinical events remained statistically significant.. These findings suggest that the important deleterious biological interactions between glucose and Creactive protein observed in vitro could also be of clinically relevance in ACS patients. (12) Although both HbA1cand admission glucose may be associated with impaired prognosis, our results indicate that increased admission glucose is more important.
Higher admission glucose is associated with higher Killip class, larger infarct size and lower ventricular function. (13) HbA1c may have limited predictive power for short-term outcomes in patients with ACS, but its association with long-term outcome may be stronger. (14) Although stress-induced hyperglycaemia can partly explain the relation between admission glucose and outcome, hyperglycaemia itself can also be harmful. The thrombotic properties of platelets are increased in a hyperglycaemic environment, and this can result in additional cardiovascular complications. (15) Moreover, recent reports suggest that glucose may be an important mediator in inflammatory responses. Elevated glucose levels induce an increase in inflammatory markers in healthy people, and hyperglycaemic patients with an acute myocardial infarction have an augmented inflammatory response compared to normoglycaemic patients. (16) Similarly, Duarte et al (17) , studying patients with ACS and complications, have found higher mean blood glucose levels, which were significantly associated with in-hospital events.
Our results showed a significant difference of mean CRP levels in patients of NSTEMI, STEMI as compared to UA patients and are in consistence with Zebrack et al (18) and Kazmierezak et al, (19) 
